Telesis Bio Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Telesis Bio current Real Value cannot be determined due to lack of data. The regular price of Telesis Bio is $0.0. Our model measures the value of Telesis Bio from inspecting the company fundamentals such as Operating Margin of (6.76) %, return on equity of -1.48, and Shares Outstanding of 1.77 M as well as reviewing its technical indicators and probability of bankruptcy.
Telesis Bio Total Value Analysis
Telesis Bio is at this time forecasted to have valuation of 61.1 M with market capitalization of 5.73 M, debt of 34.38 M, and cash on hands of 654.75 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Telesis Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
61.1 M | 5.73 M | 34.38 M | 654.75 M |
Telesis Bio Investor Information
About 38.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.11. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Telesis Bio recorded a loss per share of 30.42. The entity had not issued any dividends in recent years. The firm had 1:18 split on the 9th of May 2024. Based on the analysis of Telesis Bio's profitability, liquidity, and operating efficiency, Telesis Bio is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Telesis Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Telesis Bio has an asset utilization ratio of 39.07 percent. This suggests that the Company is making $0.39 for each dollar of assets. An increasing asset utilization means that Telesis Bio is more efficient with each dollar of assets it utilizes for everyday operations.Telesis Bio Ownership Allocation
Telesis Bio maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Telesis Bio Profitability Analysis
The company reported the previous year's revenue of 27.51 M. Net Loss for the year was (47.72 M) with profit before overhead, payroll, taxes, and interest of 15.6 M.Telesis Bio Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 29.8 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Telesis Pink Sheet
If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |